Alzheimer’s disease (AD) is a debilitating incurable disease that affects millions of patients worldwide. Deposits of amyloid beta (Aβ) amyloid in the brain is key…
Light therapy leads to significant improvements in sleep and psycho-behavioral symptoms for patients with Alzheimer’s disease, according to a new study published in PLOS ONE…
In a recent study published in Journal of the American Geriatrics Society, Veterans with housing instability were 53% more likely to receive a diagnosis of…
Around 36% of people in England with dementia are unaware they have the condition, according to a new report from the Dementia Commission.
A recent study demonstrated the safety of cilostazol in patients with mild cognitive impairment (MCI), but did not demonstrate any efficacy in preventing disease progression.…
A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer’s disease (AD). The researchers have engineered…
Most neurodegenerative diseases, including dementias, involve proteins aggregating into filaments called amyloids. In most of these diseases, researchers have identified the proteins that aggregate, allowing…
Twice daily non-invasive electrical stimulation of the brain may boost mental processes (cognitive function) in people with Alzheimer’s disease, suggest the results of a small…
Developing treatments for Alzheimer’s disease (AD) is difficult because complex underlying mechanisms drive different types of cells that may contribute to the disorder. Microglia and…
In a report launched at a lunch debate hosted by Deirdre Clune MEP (Ireland), Alzheimer Europe highlighted the continuing inequalities in access to dementia care…